Maternal-Fetal Evidence Based Guidelines (Series in Maternal-fetal Medicine) (4TH)

個数:

Maternal-Fetal Evidence Based Guidelines (Series in Maternal-fetal Medicine) (4TH)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • ≪洋書のご注文について≫ 「海外取次在庫あり」および「国内仕入れ先からお取り寄せいたします」表示の商品でもクリスマス前(12/21~12/25)および年末年始までにお届けできないことがございます。あらかじめご了承ください。

  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • 製本 Hardcover:ハードカバー版/ページ数 614 p.
  • 言語 ENG
  • 商品コード 9780367567026
  • DDC分類 618.2

Full Description

This new edition of an acclaimed text reviews the evidence for best practice in Maternal-Fetal Medicine, to present the reader with the right information, with appropriate use of proven interventions and avoidance of ineffectual or harmful ones. The information is presented in the right format by summarizing evidence succinctly and clearly in tables and algorithms. The aim is to inform the clinician, to reduce errors and "to make it easy to do it right."

The volume can be purchased separately or together with the companion volume on Obstetric Evidence Based Guidelines (set ISBN 9780367567033).

The Series in Maternal-Fetal Medicine is published in conjunction with the Journal of Maternal-Fetal and Neonatal Medicine.

From reviews of previous editions:

An excellent resource with quick and easy protocols... this book has a permanent spot on my shelf.

—Doody's Review Service

Contents

Introduction. How to "Read" this book. List of Abbreviations. List of Contributors. 1.Hypertensive disorders. 2.Cardiac disease. 3.Obesity. 4.Pregestational diabetes. 5.Gestational diabetes. 6.Hypothyroidism. 7.Hyperthyroidism. 8.Prolactinoma. 9.Nausea/vomiting of pregnancy and hyperemesis gravidarum. 10.Intrahepatic cholestasis of pregnancy. 11.Inflammatory bowel disease. 12.Alimentary tract diseases. 13.Pregnancy after liver and other transplantation. 14.Maternal anemia. 15.Sickle cell disease. 16.von Willebrand Disease. 17.Urinary tract disease. 18.Headache. 19.Seizures. 20.Other neurologic diseases in pregnancy. 21.Mood disorders. 22.Smoking. 23.Substance use disorders. 24.Intimate partner violence and trauma informed care in pregnancy. 25.Racism and racial disparity in obstetrics. 26.Respiratory diseases: asthma, pneumonia, influenza, tuberculosis, and COVID-19. 27.Systemic lupus erythematosus. 28.Antiphospholipid syndrome. 29.Inherited thrombophilia. 30.Venous thromboembolism and anticoagulation. 31.Hepatitis A. 32.Hepatitis B. 33.Hepatitis C. 34.HIV. 35.Gonorrhea. 36.Chlamydia. 37.Syphilis. 38.Trichomonas. 39.Group B Streptococcus. 40.Vaccination. 41.Trauma. 42.Critical care. 43.Amniotic fluid embolism. 44.Cancer. 45.Dermatoses of pregnancy. 46.Multiple gestations. 47.Fetal Growth Restriction. 48.Fetal macrosomia. 49.Cytomegalovirus. 50.Toxoplasmosis. 51.Parvovirus. 52.Herpes. 53.Varicella. 54.Fetal and neonatal alloimmune thrombocytopenia. 55.Hemolytic Disease of the Fetus and Newborn (HDFN). 56.Nonimmune hydrops fetalis. 57.Fetal death. 58.Antepartum testing. 59.Sonographic assessment of amniotic fluid: oligohydramnios and polyhydramnios. Index.